Paul Rennie interviewed on Marcus Today Podcast., page-7

Yes cant quote directly but definitely they are looking at a number of these biomarkers, don't forget this is the latest research and in no way would we have had these available to us way back in the very early days of trial construction a number of years ago now.

Dungiven, as you are most aware, the most exciting thing is that we have not just one world leader in this space working for us, we have two. Felson and Kraus. Dr Kraus in particular will advise the FDA and based on that no doubt we will have future discussions (as slated by PAR). It is in these discussions that suitable endpoints and further study protocols will be engineered and we will have a crystal clear pathway to success, as well on top of what we already have now, my spec views.

I look forward to possibly meeting these two at OARSI. To me at least, it will be like a music fan meeting The Rolling Stones! hahah...except I think we may gather more moss (Future indications and thus future revenue)


We grind closer.